Ozge Pamukcu1, Aydin Tuncay2, Nazmi Narin3, Ali Baykan3, Levent Korkmaz4, Mustafa Argun3, Abdullah Ozyurt3, Suleyman Sunkak3, Kazim Uzum3. 1. Erciyes University School of Medicine, Division of Pediatric Cardiology, Kayseri, Turkiye,. Electronic address: opamukcu@erciyes.edu.tr. 2. Erciyes University School of Medicine, Division of Cardiovascular Surgery, Kayseri, Turkiye. 3. Erciyes University School of Medicine, Division of Pediatric Cardiology, Kayseri, Turkiye. 4. Erciyes University School of Medicine, Division of Neonatology, Kayseri, Turkiye.
Abstract
BACKGROUND: As new devices come into the market, percutaneous techniques improve and interventionalists become more experienced; percutaneous closure gets more common in preterms. In this study we aimed to compare efficacy and safety of Patent Ductus Arteriosus closure surgically versus transcatheter method in preterms <2kg. Best of our knowledge this study is the first one that compares outcomes of surgery and percutaneous Patent Ductus Arteriosus closure in preterms. METHODS & RESULTS: Between the dates July 1997 to October 2014 in our center Patent Ductus Arteriosus of 26 patients <2kg were closed percutaneously (Group A) and 31 less than 2kg operated (Group B). Weight of patients in percutaneous Patent Ductus Arteriosus closure group was significantly more than the surgery group. Mean gestational age of the patients in Group A was 30±1.8weeks, in group B was 28.6±3.5weeks. In group A; all cases were closed successfully except 4 cases: device embolization in 2, cardiac tamponade and iatrogenic aortic coarctation were seen. Pneumomediastinum and chylothorax were the major complications of the surgery group. There was no statistically significance between complication and success rates between two groups. CONCLUSION: Percutaneous Patent Ductus Arteriosus closure is the candidate for taking the place of surgery in preterms. However, it is not applied routinely; can only be done in fully equipped large centers by experienced interventionalists.
BACKGROUND: As new devices come into the market, percutaneous techniques improve and interventionalists become more experienced; percutaneous closure gets more common in preterms. In this study we aimed to compare efficacy and safety of Patent Ductus Arteriosus closure surgically versus transcatheter method in preterms <2kg. Best of our knowledge this study is the first one that compares outcomes of surgery and percutaneous Patent Ductus Arteriosus closure in preterms. METHODS & RESULTS: Between the dates July 1997 to October 2014 in our center Patent Ductus Arteriosus of 26 patients <2kg were closed percutaneously (Group A) and 31 less than 2kg operated (Group B). Weight of patients in percutaneous Patent Ductus Arteriosus closure group was significantly more than the surgery group. Mean gestational age of the patients in Group A was 30±1.8weeks, in group B was 28.6±3.5weeks. In group A; all cases were closed successfully except 4 cases: device embolization in 2, cardiac tamponade and iatrogenic aortic coarctation were seen. Pneumomediastinum and chylothorax were the major complications of the surgery group. There was no statistically significance between complication and success rates between two groups. CONCLUSION: Percutaneous Patent Ductus Arteriosus closure is the candidate for taking the place of surgery in preterms. However, it is not applied routinely; can only be done in fully equipped large centers by experienced interventionalists.
Authors: Megan Barcroft; Christopher McKee; Darren P Berman; Rachel A Taylor; Brian K Rivera; Charles V Smith; Jonathan L Slaughter; Afif El-Khuffash; Carl H Backes Journal: Clin Perinatol Date: 2022-01-21 Impact factor: 3.430
Authors: Shyam K Sathanandam; Dan Gutfinger; Laura O'Brien; Thomas J Forbes; Matthew J Gillespie; Darren P Berman; Aimee K Armstrong; Shabana Shahanavaz; Thomas K Jones; Brian H Morray; Toby A Rockefeller; Henri Justino; David G Nykanen; Evan M Zahn Journal: Catheter Cardiovasc Interv Date: 2020-05-20 Impact factor: 2.692
Authors: Michael T Kuntz; Steven J Staffa; Dionne Graham; David Faraoni; Philip Levy; James DiNardo; Nicola Maschietto; Viviane G Nasr Journal: J Am Heart Assoc Date: 2021-12-31 Impact factor: 6.106
Authors: Shyam Sathanandam; Dan Gutfinger; Brian Morray; Darren Berman; Matthew Gillespie; Thomas Forbes; Jason N Johnson; Ruchira Garg; Sophie Malekzadeh-Milani; Alain Fraisse; Osman Baspinar; Evan M Zahn Journal: Pediatr Cardiol Date: 2021-06-30 Impact factor: 1.655